Search - tctmd.com

Displaying 821 - 840 of 1061

Sort: Relevancy | Date

News Conference News ESC 2013

PARTNER A: TAVR the Optimal Choice for Diabetic Patients at High Risk

Yael L. Maxwell

September 04, 2013

News Conference News ESC 2013

FRANCE 2: Post-TAVR Aortic Regurgitation Doubles Mortality Risk

Caitlin E. Cox

September 02, 2013

News Daily News

Surgery Best for Long-term Management of Infants with Aortic Stenosis

August 23, 2013

News Industry News

Edwards Receives Reimbursement Approval for Sapien XT Valve in Japan

August 21, 2013

News Daily News

For Inoperable Patients, TAVR Carries Benefits but Raises Lifetime Costs

July 25, 2013

News Daily News

En Pacientes Inoperables, la TAVR produce Beneficios pero Dispara el Gasto de por Vida

July 25, 2013

News Daily News

Incomplete Revascularization Does Not Hinder TAVR for Severe Aortic Stenosis

Caitlin E. Cox

July 19, 2013

News Daily News

European TAVR Usage Tied to Economics, Reimbursement

Yael L. Maxwell

July 12, 2013

News Daily News

El Uso de la TAVR en Europa se asocia a la Economía y a los Reembolsos

Yael L. Maxwell

July 12, 2013

News Daily News

Studies Zero in on Baseline Factors That Influence TAVR Outcome

Caitlin E. Cox

July 11, 2013

News Daily News

Estudios se Centran en los Factores Basales que Influyen en los Resultados TAVR

Caitlin E. Cox

July 11, 2013

News Daily News

TAVR-Associated Aortic Root Rupture Hazardous but Predictable

Caitlin E. Cox

June 28, 2013

News Daily News

La Rotura de la Raíz Aórtica secundaria a la TAVR es Peligrosa pero Predecible

Caitlin E. Cox

June 28, 2013

News Industry News

Edwards Lifesciences Receives Approval for SAPIEN XT in Japan

June 24, 2013

News Daily News

Drop in Platelet Count After TAVR Signals Poor Outcomes

Caitlin E. Cox

June 18, 2013

News Industry News

New Data on Edwards PERIMOUNT Valves Demonstrate Long-Term Durability in Patients Aged 60 and Younger

June 17, 2013

News Industry News

Medtronic Unveils Baseline Data Of Extreme Risk Patients Enrolled In CoreValve® U.S. Pivotal Trial

June 14, 2013

News Daily News

Meta-analysis: Disease Prevalence, Number of TAVR Candidates Growing

Yael L. Maxwell

May 31, 2013

News Daily News

Meta-análisis: Aumenta la prevalencia de la enfermedad y el número de candidatos a TAVR

Yael L. Maxwell

May 31, 2013

News Daily News

Tumor Marker Predicts TAVR Outcomes

May 29, 2013

Advertisement

PARTNER A: TAVR the Optimal Choice for Diabetic Patients at High Risk

FRANCE 2: Post-TAVR Aortic Regurgitation Doubles Mortality Risk

Surgery Best for Long-term Management of Infants with Aortic Stenosis

Edwards Receives Reimbursement Approval for Sapien XT Valve in Japan

For Inoperable Patients, TAVR Carries Benefits but Raises Lifetime Costs

En Pacientes Inoperables, la TAVR produce Beneficios pero Dispara el Gasto de por Vida

Incomplete Revascularization Does Not Hinder TAVR for Severe Aortic Stenosis

European TAVR Usage Tied to Economics, Reimbursement

El Uso de la TAVR en Europa se asocia a la Economía y a los Reembolsos

Studies Zero in on Baseline Factors That Influence TAVR Outcome

Estudios se Centran en los Factores Basales que Influyen en los Resultados TAVR

TAVR-Associated Aortic Root Rupture Hazardous but Predictable

La Rotura de la Raíz Aórtica secundaria a la TAVR es Peligrosa pero Predecible

Edwards Lifesciences Receives Approval for SAPIEN XT in Japan

Drop in Platelet Count After TAVR Signals Poor Outcomes

New Data on Edwards PERIMOUNT Valves Demonstrate Long-Term Durability in Patients Aged 60 and Younger

Medtronic Unveils Baseline Data Of Extreme Risk Patients Enrolled In CoreValve® U.S. Pivotal Trial

Meta-analysis: Disease Prevalence, Number of TAVR Candidates Growing

Meta-análisis: Aumenta la prevalencia de la enfermedad y el número de candidatos a TAVR

Tumor Marker Predicts TAVR Outcomes

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content